Mahesh V. Patel - 02 Jan 2025 Form 4 Insider Report for Lipocine Inc. (LPCN)

Role
Chief Executive Officer, Director
Signature
/s/ Mahesh V. Patel
Issuer symbol
LPCN
Transactions as of
02 Jan 2025
Net transactions value
+$79,563
Form type
4
Filing time
02 Jan 2025, 19:46:47 UTC
Previous filing
30 Dec 2024
Next filing
19 Dec 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPCN Stock Option (Right to Buy) Award $79,563 +16,371 +12% $4.86 149,039 02 Jan 2025 Common Stock 16,371 $4.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to vesting whereby 1/3 of the shares subject to the award will vest on January 2, 2026, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years.